Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells

Journal of Nutritional Biochemistry

Volumn 21, Issue 6, 2010, Pages 482-489

  Chao, Jianfei ^a,b   Li, Haitao ^a   Cheng, Ka Wing ^a   Yu, Man Shan ^b   Chang, Raymond Chuen Chung ^b,c   Wang, Mingfu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

6 Hydroxydopamine; Neuroprotection; Parkinson's disease; Pinostilbene; Resveratrol

Indexed keywords

CASPASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; LACTATE DEHYDROGENASE; MAMMALIAN TARGET OF RAPAMYCIN; O DEMETHYLASE; OXIDOPAMINE; PINOSTILBENE; PROTEIN C JUN; RESVERATROL; STILBENE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; NEUROTOXIN; SCAVENGER;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHOBICITY; INTERNALIZATION; METHYLATION; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; CELL CULTURE; CHEMICAL MODEL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; NERVE CELL; PHOSPHORYLATION; TUMOR CELL LINE;

MAMMALIA; PARKINSONIA;

CASPASE 3; CELL LINE, TUMOR; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; HUMANS; L-LACTATE DEHYDROGENASE; METHYLATION; MODELS, CHEMICAL; NEURONS; NEUROTOXINS; OXIDOPAMINE; PHOSPHORYLATION; STILBENES;

EID: 77952882393     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.02.004     Document Type: Article

References (49)

1. Fremont L. Biological effects of resveratrol. Life Sci 2000, 66:663-673.
2. Burns J., Yokota T., Ashihara H., Lean M.E., Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem 2002, 50:3337-3340.
3. Bhat K.P.L., Kosmeder J.W., Pezzuto J.M. Biological effects of resveratrol. Antioxid Redox Signal 2001, 3:1041-1064.
4. Han Y.S., Zheng W.H., Bastianetto S., Chabot J.G., Quirion R. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 2004, 141:997-1005.
5. Marambaud P., Zhao H., Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 2005, 280:37377-37382.
6. Kumar A., Naidu P.S., Seghal N., Padi S.S. Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacol 2007, 79:17-26.
7. Kumar P., Padi S.S., Naidu P.S., Kumar A. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 2006, 17:485-492.
8. Sonmez U., Sonmez A., Erbil G., Tekmen I., Baykara B. Neuroprotective effects of resveratrol against traumatic brain injury in immature rats. Neurosci Lett 2007, 420:133-137.
9. Ates O., Cayli S., Altinoz E., Gurses I., Yucel N., Sener M., et al. Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem 2007, 294:137-144.
10. Lu K.T., Chiou R.Y., Chen L.G., Chen M.H., Tseng W.T., Hsieh H.T., et al. Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation. J Agric Food Chem 2006, 54:3126-3131.
11. Lu K.T., Ko M.C., Chen B.Y., Huang J.C., Hsieh C.W., Lee M.C., et al. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 2008, 56:6910-6913.
12. Walle T., Hsieh F., DeLegge M.H., Oatis J.E., Walle U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004, 32:1377-1382.
13. Rivera H., Shibayama M., Tsutsumi V., Perez-Alvarez V., Muriel P. Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat. J Appl Toxicol 2008, 28:147-155.
14. Schneider Y., Chabert P., Stutzmann J., Coelho D., Fougerousse A., Goss F., et al. Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int J Cancer 2003, 107:189-196.
15. Orsini F., Verotta L., Lecchi M., Restano R., Curia G., Redaelli E., et al. Resveratrol derivatives and their role as potassium channels modulators. J Nat Prod 2004, 67:421-426.
16. Lai S.W., Yu M.S., Yuen W.H., Chang R.C.C. Novel neuroprotective effects of the aqueous extracts from Verbena officinalis Linn. Neuropharmacology 2006, 50:641-650.
17. Yu M.S., Lai C.S., Ho Y.S., Zee S.Y., So K.F., Yuen W.H., et al. Characterization of the effects of anti-aging medicine Fructus lycii on beta-amyloid peptide neurotoxicity. Int J Mol Med 2007, 20:261-268.
18. Ho Y.S., Yu M.S., Lai C.S., So K.F., Yuen W.H., Chang R.C.C. Characterizing the neuroprotective effects of alkaline extract of Lycium barbarum on beta-amyloid peptide neurotoxicity. Brain Res 2007, 1158:123-134.
19. Lai C.S.W., Yu M.S., Yuen W.H., So K.F., Zee S.Y., Chang R.C.C. Antagonizing [beta]-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res 2008, 1190:215-224.
20. Chang R.C.C., Suen K.C., Ma C.H., Elyaman W., Ng H.K., Hugon J. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2α in neuronal degeneration. J Neurochem 2002, 83:1215-1225.
21. Suen K.C., Yu M.S., So K.F., Chang R.C.C., Hugon J. Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity. J Biol Chem 2003, 278:49819-49827.
22. Suen K.C., Lin K.F., Elyaman W., So K.F., Chang R.C.C., Hugon J. Reduction of calcium release from the endoplasmic reticulum could only provide partial neuroprotection against beta-amyloid peptide toxicity. J Neurochem 2003, 87:1413-1426.
23. Lin K.F., Chang R.C.C., Suen K.C., So K.F., Hugon J. Modulation of calcium/calmodulin kinase-II provides partial neuroprotection against beta-amyloid peptide toxicity. Eur J Neurosci 2004, 19:2047-2055.
24. Yu M.S., Leung S.K., Lai S.W., Che C.M., Zee S.Y., So K.F., et al. Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity. Exp Gerontol 2005, 40:716-727.
25. Yu M.S., Suen K.C., Kwok N.S., So K.F., Hugon J., Chang R.C.C. Beta-amyloid peptides induces neuronal apoptosis via a mechanism independent of unfolded protein responses. Apoptosis 2006, 11:687-700.
26. Chao J., Yu M.S., Ho Y.S., Wang M., Chang R.C.C. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic Biol Med 2008, 45:1019-1026.
27. Lee H.H., Lin C.T., Yang L.L. Neuroprotection and free radical scavenging effects of Osmanthus fragrans. J Biomed Sci 2007, 14:819-827.
28. Xu B.J., Yuan S.H., Chang S.K.C. Comparative analyses of phenolic composition, antioxidant capacity, and color of cool season legumes and other selected food legumes. J Food Sci 2007, 72:S167-S177.
29. Fang X., Yu M.M., Yuen W.H., Zee S.Y., Chang R.C. Immune modulatory effects of Prunella vulgaris L. on monocytes/macrophages. Int J Mol Med 2005, 16:1109-1116.
30. Yu M.S., Ho Y.S., So K.F., Yuen W.H., Chang R.C. Cytoprotective effects of Lycium barbarum against reducing stress on endoplasmic reticulum. Int J Mol Med 2006, 17:1157-1161.
31. +-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J Neurosci Res 1999, 57:86-94.
32. Borsello T., Forloni G. JNK signalling: a possible target to prevent neurodegeneration. Curr Pharm Des 2007, 13:1875-1886.
33. Choi W.S., Eom D.S., Han B.S., Kim W.K., Han B.H., Choi E.J., et al. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem 2004, 279:20451-20460.
34. Fujita H., Ogino T., Kobuchi H., Fujiwara T., Yano H., Akiyama J., et al. Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the Akt pathway. Brain Res 2006, 1113:10-23.
35. Glinka Y., Gassen M., Youdim M.B. Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm Suppl 1997, 50:55-66.
36. Auger C., Teissedre P.L., Gerain P., Lequeux N., Bornet A., Serisier S., et al. Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J Agric Food Chem 2005, 53:2015-2021.
37. Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 2006, 545:51-64.
38. Ma Z., Wei X., Fontanilla C., Noelker C., Dodel R., Hampel H., et al. Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity. Life Sci 2006, 79:1307-1311.
39. Wolter F., Clausnitzer A., Akoglu B., Stein J. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J Nutr 2002, 132:298-302.
40. Stojanovic S., Sprinz H., Brede O. Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation. Arch Biochem Biophys 2001, 391:79-89.
41. Stivala L.A., Savio M., Carafoli F., Perucca P., Bianchi L., Maga G., et al. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 2001, 276:22586-22594.
42. Matsuoka A., Takeshita K., Furuta A., Ozaki M., Fukuhara K., Miyata N. The 4'-hydroxy group is responsible for the in vitro cytogenetic activity of resveratrol. Mutat Res 2002, 521:29-35.
43. Lu Z., Nie G., Belton P.S., Tang H., Zhao B. Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. Neurochem Int 2006, 48:263-274.
44. Deng S.L., Chen W.F., Zhou B., Yang L., Liu Z.L. Protective effects of curcumin and its analogues against free radical-induced oxidative haemolysis of human red blood cells. Food Chem 2006, 98:112-119.
45. Heynekamp J.J., Weber W.M., Hunsaker L.A., Gonzales A.M., Orlando R.A., Deck L.M., et al. Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. J Med Chem 2006, 49:7182-7189.
46. Murias M., Handler N., Erker T., Pleban K., Ecker G., Saiko P., et al. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 2004, 12:5571-5578.
47. Zheng L.F., Wei Q.Y., Cai Y.J., Fang J.G., Zhou B., Yang L., et al. DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu (II) ions: mechanism and structure-activity relationship. Free Radic Bio Med 2006, 41:1807-1816.
48. Malagelada C., Ryu E.J., Biswas S.C., Jackson-Lewis V., Greene L.A. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. J Neurosci 2006, 26:9996-10005.
49. Chen G., Bower K.A., Ma C., Fang S., Thiele C.J., Luo J. Glycogen synthase kinase 3β (GSK3β) mediates 6-hydroxydopamine-induced neuronal death. FASEB J 2004, 18:1162-1164.